Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
476 people get XNPT articles and Market Currents by email alert.
Get email alerts on XNPT »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Fri, 8:30AM)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 18, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 4, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Hedge Fund Bridger Management Ups XenoPort StakeMarket Folly • Tue, Jul 20, 2010
-
Steven Cohen's SAC Capital Discloses New XenoPort StakeMarket Folly • Tue, May 25, 2010
-
XenoPort's Solzira a Potential BlockbusterZacks Investment Research • Wed, Jun 17, 2009
-
Glaxo And Human Genome Have Apparently Seen ReasonStephen Simpson • Mon, Jul 16, 2012
-
6 Highly Liquid Biotech Stocks With Positive Correlation To VolatilityKapitall • Tue, Jan 31, 2012
-
11 Biotech Stocks With Bullish Short TrendsKapitall • Wed, Nov 23, 2011
-
14 Oversold Tech Stocks Undervalued by Target PriceKapitall • Tue, Nov 22, 2011
-
20 Oversold Stocks Deeply Undervalued By Target PriceKapitall • Fri, Nov 11, 2011
-
XenoPort's CEO Discusses Q3 2012 Results - Earnings Call TranscriptWed, Oct 24, 2012
-
Xenoport's CEO Discusses Q2 2012 Results - Earnings Call TranscriptTue, Aug 7, 2012
-
XenoPort, Inc. Q2 2009 Earnings Call TranscriptWed, Aug 5, 2009
-
XenoPort, Inc., Q1 2009 Earnings Call Transcript.Tue, May 5, 2009
-
XenoPort Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
XenoPort, Inc. Q3 2008 Earnings Call TranscriptMon, Nov 24, 2008
-
XenoPort Inc.Q2 2008 Earnings Call TranscriptWed, Aug 6, 2008
-
Xenoport, Inc. Q1 2008 Earnings Call TranscriptTue, May 13, 2008
-
XenoPort Incorporated Q4 2007 Earnings Call TranscriptThu, Feb 14, 2008
-
XenoPort Business Update Call TranscriptTue, Jan 22, 2008
-
Xenoport Q3 2007 Earnings Call TranscriptWed, Nov 7, 2007
-
Business Wire (Fri, 8:30AM)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 24, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 18, 2013)
-
Business Wire (Mar 11, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Feb 4, 2013)
-
Business Wire (Jan 4, 2013)
-
Business Wire (Dec 7, 2012)
-
Business Wire (Nov 16, 2012)
-
at MarketWatch.com (Nov 8, 2012)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Nov 2, 2012)
XNPT vs. ETF Alternatives
Company Description
Currently, there's no company description for XNPT.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 21, 12:26 PM Deutsche Bank isn't ready to give up on XenoPort (XNPT -3.1%) just yet. Despite the disappointing arbaclofen placarbil Phase 3 trial results reported Monday and the subsequent ~22% share price decline, analyst Greg Poole reiterates his Buy rating on the shares albeit with a lower price target of $9 ($12 previous). Comment! [Healthcare, On the Move]
-
Monday, May 20, 12:45 PM
Midday top 10 gainers: AQ +115%. MEAD +104%. RSOL +50%. JASO +46%. CAMT +44%. PACT +32%. HSOL +31%. WBSN +28%. CSUN +27%. PPHM +20%.
Midday top 10 losers: NBG -28%. TISI -17%. IEC -14%. XNPT -12%. VBFC -11%. CHCI -9%. RAVN -9%. SBSA -9%. OSIS -9%. INSY -9%. Comment! [On the Move] -
Monday, May 20, 9:10 AM
Premarket gainers: AQ +116%. MEAD +97%. PACT +38%. WBSN +28%. RSOL +26%. ROSG +16%. JASO +16%. JRCC +14%. QIHU +12%. LDK +9%. PXP +7%. IQNT +5%. VOYA +5%. DANG +5%.
Losers: XNPT -26%. NBG -8%. Comment! [On the Move] - Monday, May 20, 8:04 AM Xenoport (XNPT) plummets 19.26% premarket after saying data from a Phase 3 clinical trial of arbaclofen placarbil did not demonstrate that the treatment provides statistically significant improvement versus a placebo in patients with spasticity due to multiple sclerosis. The company will "terminate further investment in the program." (PR) Comment! [Healthcare, On the Move]
- Wednesday, April 24, 4:27 PM Xenoport (XNPT): Q1 EPS of -$0.50 misses by $0.07. Revenue of $0.5M misses by $0.7M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, April 12, 7:49 AM XenoPort (XNPT) says its restless leg drug Horizant is sold out, and in this case, that's a bad thing. GlaxoSmithKline (GSK), which has commercialization rights to the treatment through the end of this month, reports manufacturing delays have led to a stockout of Horizant. XNPT says it is "evaluating the impact, if any, this will have" on financial expectations. Shares -2.48% premarket. 1 Comment [Healthcare, On the Move]
- Wednesday, March 20, 10:59 AM Wells Fargo's Brian Abrahams is defending XenoPort (XNPT -2.6%) this morning on the back of competitor Biogen's (BIIB +1.5%) positive trial results for its MS treatment Plegridy. He says that, despite the competition, BIIB's multiple sclerosis pill patents should be a positive for XNPT. Most notably, additional patent applications could provide patent protection until 2032 for BIIB's BG-12, which should benefit XNPT's '829 drug, an earlier stage derivative of BG-12, and give it added protection from generic competition. Comment! [Healthcare, On the Move]
-
Tuesday, March 12, 5:48 PM
After-hours top gainers, as of 5:15 p.m.: XNPT +11%. DTSI +8%. ARQL +8%. SGMS +7%. EVER +7%.
After-hours top losers: SPPI -35%. VELT -26%. KTOS -16%. MUX -8%. TEU -8%. 3 Comments [On the Move] - Monday, March 11, 4:09 PM Xenoport (XNPT): Q4 EPS of $0.07 beats by $0.49. Revenue of $0.5M misses by $0.52M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Monday, March 11, 12:10 AM Notable earnings after Monday’s close: CASY, CQB, CVI, DMND, FCEL, HEK, HMIN, PWRD, XNPT Comment! [Earnings]
- Sunday, March 10, 5:35 PM Notable earnings after Monday’s close: CASY, CQB, CVI, DMND, FCEL, HEK, HMIN, PWRD, XNPT Comment! [Earnings]
- Tuesday, February 12, 12:10 AM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Monday, February 11, 5:35 PM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Wednesday, October 24, 2012, 4:25 PM XenoPort (XNPT): Q3 EPS of -$0.41 beats by $00.02. Revenue of $379K (flat% Y/Y) . (PR) Comment! [Earnings, Healthcare]
- Wednesday, October 24, 2012, 12:10 AM Notable earnings after Wednesday’s close: AB, ACOM, AEM, AKAM, AMP, CCI, CDNS, CLF, CMO, CROX, CTXS, EGHT, ENTR, EQR, FFIV, FIO, IDCC, INFN, KBR, LOGI, LSI, OI, ORLY, RRC, RYL, SGMO, SIMO, SPN, SRCL, SYMC, SYNC, TAL, TER, TEX, TLAB, TQNT, TRN, TSCO, TWI, WLL, WYNN, XNPT, ZNGA Comment! [Earnings]
- Tuesday, October 23, 2012, 5:35 PM Notable earnings after Wednesday’s close: AB, ACOM, AEM, AKAM, AMP, CCI, CDNS, CLF, CMO, CROX, CTXS, EGHT, ENTR, EQR, FFIV, FIO, IDCC, INFN, KBR, LOGI, LSI, OI, ORLY, RRC, RYL, SGMO, SIMO, SPN, SRCL, SYMC, SYNC, TAL, TER, TEX, TLAB, TQNT, TRN, TSCO, TWI, WLL, WYNN, XNPT, ZNGA Comment! [Earnings]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.










